Genoil Inc.
GNOLF
$0.01
$0.000.00%
| Weiss Ratings | GNOLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Very Weak | |||
| Risk Grade | E+ | |||
| Reward Grade | E | |||
| Rating Factors | GNOLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Very Weak | |||
| Total Return Index | Fair | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | GNOLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 2,051.06 | |||
| Price History | GNOLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.00% | |||
| 30-Day Total Return | 11.11% | |||
| 60-Day Total Return | 66.67% | |||
| 90-Day Total Return | 1,900.00% | |||
| Year to Date Total Return | 42.86% | |||
| 1-Year Total Return | -- | |||
| 2-Year Total Return | 9,900.00% | |||
| 3-Year Total Return | 100.00% | |||
| 5-Year Total Return | -41.18% | |||
| 52-Week High % Change | -50.00% | |||
| 52-Week Low % Change | 999,900.00% | |||
| Price | GNOLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.02 | |||
| 52-Week Low Price | $0.00 | |||
| 52-Week Low Price (Date) | Mar 11, 2024 | |||
| 52-Week High Price (Date) | Feb 13, 2025 | |||
| Valuation | GNOLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 19.61M | |||
| Enterprise Value | 19.80M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | 0.00 | |||
| Earnings Per Share Growth | -85.48% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | -100.00 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $0.01 | |||
| Enterprise Value/EBITDA (TTM) | -- | |||
| Enterprise Value/EBIT | -10.18 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | GNOLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 1.95B | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | GNOLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 212 688 8868 | |||
| Address | One Rockefeller Center New York, NY 10020 | |||
| Website | genoil.ca | |||
| Country | United States | |||
| Year Founded | 1996 | |||
| Profitability | GNOLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -- | |||
| Profit Margin | -- | |||
| Management Effectiveness | GNOLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -382.37% | |||
| Return on Equity | -- | |||
| Income Statement | GNOLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | |||
| Total Revenue (TTM) | -- | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | -- | |||
| EBITDA (TTM) | -- | |||
| EBIT (TTM) | -1.95M | |||
| Net Income (TTM) | -1.65M | |||
| Net Income Avl. to Common (TTM) | -1.65M | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | -0.97% | |||
| EPS Diluted (TTM) | 0.00 | |||
| EPS Diluted Growth (Q YOY) | 0.00% | |||
| Balance Sheet | GNOLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 14.90K | |||
| Cash Per Share (Q) | $0.00 | |||
| Total Current Assets (Q) | 90.30K | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | -147.30K | |||
| Current Ratio (Q) | 0.434 | |||
| Book Value Per Share (Q) | $0.00 | |||
| Total Assets (Q) | 268.90K | |||
| Total Current Liabilities (Q) | 207.90K | |||
| Total Debt (Q) | 208.20K | |||
| Total Liabilities (Q) | 416.10K | |||
| Total Common Equity (Q) | -147.30K | |||
| Cash Flow | GNOLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -- | |||
| Cash from Financing (TTM) | 738.10K | |||
| Net Change in Cash (TTM) | -6.80K | |||
| Levered Free Cash Flow (TTM) | -39.40K | |||
| Cash from Operations (TTM) | -744.90K | |||
